Answers are grounded in this paper and cite their sources.
The review presents literature on the epidemiology of chronic venous diseases (CVD) and chronic venous insufficiency (CVI). The main approaches to the choice of conservative therapy for CVD and CVI are presented. The rationality of symptomatic treatment of this category of patients is justified. Data on clinical effects and mechanisms of their realization in the preparation of calcium dobesilate are given. The results of preclinical and clinical studies to assess the efficacy and safety of calcium dobesilate in relation to the symptomatic treatment of CVD and CVI are presented. On the basis of the analysis of literary sources the conclusion on expediency of wide application of calcium dobesilate in phlebological practice is presented.
No takes yet. Share an insight, caveat, or question.
М Н Кудыкин (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: